Regulation of signal transduction activity in normal and cancer cells

George Weber, Fei Shen, Hongyuan Yang, Noemi Prajda, Wei Li

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The purpose of this investigation is to clarify critical aspects of the behavior and regulation of signal transduction activity in normal and cancer cells. Materials and Methods. Signal transduction activity was determined by measuring the steady-state activity of the three synthetic enzymes involved in the conversion of 1-phosphatidylinositol to IP3, PI 4-kinase, PI 4-phosphate 5-kinase and phospholipase C. These enzymic activities were opposed by the activities of the degradative enzymes, 4-phosphatase and 5-phosphatase. Results. We observed in hepatocellular carcinomas the operation of an integrated imbalance in signal transduction which was manifested in the up-regulation of the steady-state activities of the three synthetic enzymes and in the reduction of the activities of the two catabolic phosphatases. As a consequence of this enzyme imbalance there was an increase in the concentration of IP3 in hepatomas. Increased IP3 levels were also observed in numerous human carcinomas in clinical samples and in tissue culture cells. The signal transduction activity was subject to nutritional regulation and to drug action. The elevated signal transduction activity, as measured by the IP3 concentration, was down-regulated in a time- and dose-dependent fashion by the anticancer drug, tiazofurin, by the flavonoids, quercetin and genistein, and by the anti-estrogen receptor, tamoxifen. Conclusions. Our studies show that signal transduction activity is stringently linked with transformation and progression in rat and human carcinomas. Down-regulation of signal transduction activity by various drugs led to a marked reduction of IP3 concentration and then to apoptosis and induced differentiation.

Original languageEnglish
Pages (from-to)3703-3709
Number of pages7
JournalAnticancer Research
Volume19
Issue number5 A
StatePublished - 1999

Fingerprint

Signal Transduction
Phosphoric Monoester Hydrolases
Neoplasms
Enzymes
tiazofurin
Hepatocellular Carcinoma
Carcinoma
1-Phosphatidylinositol 4-Kinase
Genistein
Drug and Narcotic Control
Quercetin
Type C Phospholipases
Tamoxifen
Phosphatidylinositols
Flavonoids
Estrogen Receptors
Pharmaceutical Preparations
Phosphotransferases
Up-Regulation
Down-Regulation

Keywords

  • 4-Phosphatase
  • 5-Phosphatase
  • C
  • Genistein
  • Human breast carcinoma
  • Human colon carcinoma
  • Human ovarian carcinoma
  • IP
  • Phospholipase
  • PI kinase
  • PIP kinase
  • Quercetin
  • Rat hepatomas
  • Signal transduction
  • Tamoxifen
  • Tiazofurin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Weber, G., Shen, F., Yang, H., Prajda, N., & Li, W. (1999). Regulation of signal transduction activity in normal and cancer cells. Anticancer Research, 19(5 A), 3703-3709.

Regulation of signal transduction activity in normal and cancer cells. / Weber, George; Shen, Fei; Yang, Hongyuan; Prajda, Noemi; Li, Wei.

In: Anticancer Research, Vol. 19, No. 5 A, 1999, p. 3703-3709.

Research output: Contribution to journalArticle

Weber, G, Shen, F, Yang, H, Prajda, N & Li, W 1999, 'Regulation of signal transduction activity in normal and cancer cells', Anticancer Research, vol. 19, no. 5 A, pp. 3703-3709.
Weber G, Shen F, Yang H, Prajda N, Li W. Regulation of signal transduction activity in normal and cancer cells. Anticancer Research. 1999;19(5 A):3703-3709.
Weber, George ; Shen, Fei ; Yang, Hongyuan ; Prajda, Noemi ; Li, Wei. / Regulation of signal transduction activity in normal and cancer cells. In: Anticancer Research. 1999 ; Vol. 19, No. 5 A. pp. 3703-3709.
@article{6eea64115ba14e75a32f9dd4707485ec,
title = "Regulation of signal transduction activity in normal and cancer cells",
abstract = "The purpose of this investigation is to clarify critical aspects of the behavior and regulation of signal transduction activity in normal and cancer cells. Materials and Methods. Signal transduction activity was determined by measuring the steady-state activity of the three synthetic enzymes involved in the conversion of 1-phosphatidylinositol to IP3, PI 4-kinase, PI 4-phosphate 5-kinase and phospholipase C. These enzymic activities were opposed by the activities of the degradative enzymes, 4-phosphatase and 5-phosphatase. Results. We observed in hepatocellular carcinomas the operation of an integrated imbalance in signal transduction which was manifested in the up-regulation of the steady-state activities of the three synthetic enzymes and in the reduction of the activities of the two catabolic phosphatases. As a consequence of this enzyme imbalance there was an increase in the concentration of IP3 in hepatomas. Increased IP3 levels were also observed in numerous human carcinomas in clinical samples and in tissue culture cells. The signal transduction activity was subject to nutritional regulation and to drug action. The elevated signal transduction activity, as measured by the IP3 concentration, was down-regulated in a time- and dose-dependent fashion by the anticancer drug, tiazofurin, by the flavonoids, quercetin and genistein, and by the anti-estrogen receptor, tamoxifen. Conclusions. Our studies show that signal transduction activity is stringently linked with transformation and progression in rat and human carcinomas. Down-regulation of signal transduction activity by various drugs led to a marked reduction of IP3 concentration and then to apoptosis and induced differentiation.",
keywords = "4-Phosphatase, 5-Phosphatase, C, Genistein, Human breast carcinoma, Human colon carcinoma, Human ovarian carcinoma, IP, Phospholipase, PI kinase, PIP kinase, Quercetin, Rat hepatomas, Signal transduction, Tamoxifen, Tiazofurin",
author = "George Weber and Fei Shen and Hongyuan Yang and Noemi Prajda and Wei Li",
year = "1999",
language = "English",
volume = "19",
pages = "3703--3709",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 A",

}

TY - JOUR

T1 - Regulation of signal transduction activity in normal and cancer cells

AU - Weber, George

AU - Shen, Fei

AU - Yang, Hongyuan

AU - Prajda, Noemi

AU - Li, Wei

PY - 1999

Y1 - 1999

N2 - The purpose of this investigation is to clarify critical aspects of the behavior and regulation of signal transduction activity in normal and cancer cells. Materials and Methods. Signal transduction activity was determined by measuring the steady-state activity of the three synthetic enzymes involved in the conversion of 1-phosphatidylinositol to IP3, PI 4-kinase, PI 4-phosphate 5-kinase and phospholipase C. These enzymic activities were opposed by the activities of the degradative enzymes, 4-phosphatase and 5-phosphatase. Results. We observed in hepatocellular carcinomas the operation of an integrated imbalance in signal transduction which was manifested in the up-regulation of the steady-state activities of the three synthetic enzymes and in the reduction of the activities of the two catabolic phosphatases. As a consequence of this enzyme imbalance there was an increase in the concentration of IP3 in hepatomas. Increased IP3 levels were also observed in numerous human carcinomas in clinical samples and in tissue culture cells. The signal transduction activity was subject to nutritional regulation and to drug action. The elevated signal transduction activity, as measured by the IP3 concentration, was down-regulated in a time- and dose-dependent fashion by the anticancer drug, tiazofurin, by the flavonoids, quercetin and genistein, and by the anti-estrogen receptor, tamoxifen. Conclusions. Our studies show that signal transduction activity is stringently linked with transformation and progression in rat and human carcinomas. Down-regulation of signal transduction activity by various drugs led to a marked reduction of IP3 concentration and then to apoptosis and induced differentiation.

AB - The purpose of this investigation is to clarify critical aspects of the behavior and regulation of signal transduction activity in normal and cancer cells. Materials and Methods. Signal transduction activity was determined by measuring the steady-state activity of the three synthetic enzymes involved in the conversion of 1-phosphatidylinositol to IP3, PI 4-kinase, PI 4-phosphate 5-kinase and phospholipase C. These enzymic activities were opposed by the activities of the degradative enzymes, 4-phosphatase and 5-phosphatase. Results. We observed in hepatocellular carcinomas the operation of an integrated imbalance in signal transduction which was manifested in the up-regulation of the steady-state activities of the three synthetic enzymes and in the reduction of the activities of the two catabolic phosphatases. As a consequence of this enzyme imbalance there was an increase in the concentration of IP3 in hepatomas. Increased IP3 levels were also observed in numerous human carcinomas in clinical samples and in tissue culture cells. The signal transduction activity was subject to nutritional regulation and to drug action. The elevated signal transduction activity, as measured by the IP3 concentration, was down-regulated in a time- and dose-dependent fashion by the anticancer drug, tiazofurin, by the flavonoids, quercetin and genistein, and by the anti-estrogen receptor, tamoxifen. Conclusions. Our studies show that signal transduction activity is stringently linked with transformation and progression in rat and human carcinomas. Down-regulation of signal transduction activity by various drugs led to a marked reduction of IP3 concentration and then to apoptosis and induced differentiation.

KW - 4-Phosphatase

KW - 5-Phosphatase

KW - C

KW - Genistein

KW - Human breast carcinoma

KW - Human colon carcinoma

KW - Human ovarian carcinoma

KW - IP

KW - Phospholipase

KW - PI kinase

KW - PIP kinase

KW - Quercetin

KW - Rat hepatomas

KW - Signal transduction

KW - Tamoxifen

KW - Tiazofurin

UR - http://www.scopus.com/inward/record.url?scp=0032786225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032786225&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 3703

EP - 3709

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 A

ER -